88 related articles for article (PubMed ID: 7308668)
1. Mechanism of natural resistance to vincristine in rat ascites hepatoma AH66.
Inaba M; Takayama K; Sakurai Y
Gan; 1981 Aug; 72(4):562-8. PubMed ID: 7308668
[TBL] [Abstract][Full Text] [Related]
2. Increase of sensitivity and uptake of vinblastine by reserpine in rat ascites hepatoma.
Wakusawa S; Miyamoto K; Koshiura R
Jpn J Pharmacol; 1984 Oct; 36(2):187-95. PubMed ID: 6513200
[TBL] [Abstract][Full Text] [Related]
3. Enhanced efflux of actinomycin D, vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemia.
Inaba M; Sakurai Y
Cancer Lett; 1979 Dec; 8(2):111-5. PubMed ID: 555868
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance in Yoshida rat ascites hepatoma cell lines.
Miyamoto K; Wakusawa S; Nakamura S; Tajima K; Hidaka H
Anticancer Res; 1992; 12(3):649-53. PubMed ID: 1622121
[TBL] [Abstract][Full Text] [Related]
5. Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1978 Dec; 61(6):1521-4. PubMed ID: 281559
[TBL] [Abstract][Full Text] [Related]
6. Characterization of naturally acquired multiple-drug resistance of Yoshida rat ascites hepatoma AH66 cell line.
Miyamoto K; Wakabayashi D; Minamino T; Nomura M; Wakusawa S; Nakamura S
Anticancer Res; 1996; 16(3A):1235-40. PubMed ID: 8702243
[TBL] [Abstract][Full Text] [Related]
7. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
Inaba M; Kobayashi H; Sakurai Y; Johnson RK
Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418
[TBL] [Abstract][Full Text] [Related]
8. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
[TBL] [Abstract][Full Text] [Related]
9. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia.
Inaba M; Johnson RK
Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743
[TBL] [Abstract][Full Text] [Related]
10. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
[TBL] [Abstract][Full Text] [Related]
11. Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia.
Inaba M; Fujikura R; Sakurai Y
Biochem Pharmacol; 1981 Jul; 30(13):1863-5. PubMed ID: 7271878
[No Abstract] [Full Text] [Related]
12. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
13. Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells.
Itoh Y; Tamai M; Yokogawa K; Nomura M; Moritani S; Suzuki H; Sugiyama Y; Miyamoto K
Anticancer Res; 2002; 22(3):1649-53. PubMed ID: 12168849
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to antitumor drugs and vinblastine binding to membrane in rat ascites hepatoma AH66 cells.
Wakusawa S; Nakamura S; Inoko K; Miyamoto K
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2182-4. PubMed ID: 1423778
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of active efflux of vincristine from multidrug-resistant P388 leukemia cells.
Inaba M; Watanabe T; Sugiyama Y
Jpn J Cancer Res; 1987 Apr; 78(4):397-404. PubMed ID: 3108219
[TBL] [Abstract][Full Text] [Related]
16. Restored in vitro sensitivity of adriamycin- and vincristine-resistant P388 leukemia with reserpine.
Inaba M; Fujikura R; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1981 Aug; 30(15):2191-4. PubMed ID: 7295334
[No Abstract] [Full Text] [Related]
17. Conjugated bilirubin induces multidrug resistance-associated protein 2 mRNA expression and in vivo cisplatin resistance in rat hepatoma AH66 cells.
Tamai M; Ito Y; Mirura H; Tsukada H; Yokogawa K; Nomura M; Moritani S; Miyamoto K
Anticancer Res; 2003; 23(6C):4781-7. PubMed ID: 14981926
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
Nakamura S; Minamino T; Nomura M; Wakusawa S; Miyamoto K; Hidaka H
Biol Pharm Bull; 1996 Jun; 19(6):886-9. PubMed ID: 8799494
[TBL] [Abstract][Full Text] [Related]
19. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Nov; 42(11):4730-3. PubMed ID: 7127307
[TBL] [Abstract][Full Text] [Related]
20. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
Politi PM; Sinha BK
Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
